Home/Filings/4/0000899243-20-033832
4//SEC Filing

GUY GEOFFREY W DR 4

Accession 0000899243-20-033832

CIK 0001351288other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 9:30 PM ET

Size

28.1 KB

Accession

0000899243-20-033832

Insider Transaction Report

Form 4
Period: 2020-12-07
Transactions
  • Sale

    Ordinary Shares

    2020-12-07$11.19/sh14,340$160,4655,060,461 total
  • Sale

    Ordinary Shares

    2020-12-07$11.40/sh14,760$168,2645,032,441 total
  • Sale

    Ordinary Shares

    2020-12-07$10.80/sh79,596$859,6375,421,925 total
  • Sale

    Ordinary Shares

    2020-12-07$11.04/sh85,980$949,2195,143,957 total
  • Sale

    Ordinary Shares

    2020-12-07$11.44/sh10,920$124,9255,021,521 total
  • Sale

    Ordinary Shares

    2020-12-07$10.87/sh55,332$601,4595,366,593 total
  • Sale

    Ordinary Shares

    2020-12-07$10.97/sh136,656$1,499,1165,229,937 total
  • Sale

    Ordinary Shares

    2020-12-07$11.13/sh69,156$769,7065,074,801 total
  • Sale

    Ordinary Shares

    2020-12-07$11.28/sh13,260$149,5735,047,201 total
  • Sale

    Ordinary Shares

    2020-12-08$10.69/sh72,936$779,6864,948,585 total
  • Sale

    Ordinary Shares

    2020-12-08$10.76/sh167,064$1,797,6094,781,521 total
Footnotes (13)
  • [F1]Inadvertently late filing.
  • [F10]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($136.77 per ADS). These shares were sold in multiple transactions at prices ranging from $136.06 per ADS (or $11.34 per ordinary share) to $137.00 per ADS (or $11.42 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F11]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($137.30 per ADS). These shares were sold in multiple transactions at prices ranging from $137.07 per ADS (or $11.42 per ordinary share) to $137.49 per ADS (or $11.46 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F12]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($128.24 per ADS). These shares were sold in multiple transactions at prices ranging from $127.69 per ADS (or $10.64 per ordinary share) to $128.68 per ADS (or $10.72 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F13]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($129.06 per ADS). These shares were sold in multiple transactions at prices ranging from $128.70 per ADS (or $10.73 per ordinary share) to $129.63 per ADS (or $10.80 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]Represented by American Depository Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  • [F3]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($129.58 per ADS). These shares were sold in multiple transactions at prices ranging from $129.02 per ADS (or $10.75 per ordinary share) to $130.00 per ADS (or $10.83 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($130.47 per ADS). These shares were sold in multiple transactions at prices ranging from $130.05 per ADS (or $10.84 per ordinary share) to $131.01 per ADS (or $10.92 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($131.69 per ADS). These shares were sold in multiple transactions at prices ranging from $131.04 per ADS (or $10.92 per ordinary share) to $132.02 per ADS (or $11.00 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F6]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.43 per ADS). These shares were sold in multiple transactions at prices ranging from $132.02 per ADS (or $11.00 per ordinary share) to $133.01 per ADS (or $11.08 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($133.54 per ADS). These shares were sold in multiple transactions at prices ranging from $133.02 per ADS (or $11.09 per ordinary share) to $134.01 per ADS (or $11.17 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F8]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($134.28 per ADS). These shares were sold in multiple transactions at prices ranging from $134.02 per ADS (or $11.17 per ordinary share) to $135.00 per ADS (or $11.25 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F9]Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($135.41 per ADS). These shares were sold in multiple transactions at prices ranging from $135.10 per ADS (or $11.26 per ordinary share) to $135.80 per ADS (or $11.32 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

GW PHARMACEUTICALS PLC

CIK 0001351288

Entity typeother

Related Parties

1
  • filerCIK 0000941388

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 9:30 PM ET
Size
28.1 KB